Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lenvatinib in Pediatric Solid Tumors and Osteosarcoma
NCT02432274Phase 2Completed
- Sponsor
- Eisai Co., Ltd.
- Start
- Dec 2014
- Primary completion
- Jul 2019
- Modality
- Small Molecules
- Countries
- 6
01
Overview
A Phase 2 trial of lenvatinib in solid tumor, differentiated thyroid carcinoma (DTC), osteosarcoma (OS), sponsored by Eisai Co., Ltd.. Started Dec 2014; status: completed.
02
Drugs
lenvatinib
03
Conditions
solid tumordifferentiated thyroid carcinoma (DTC)osteosarcoma (OS)
Beyond the preview
Go deeper on NCT02432274.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02432274.